<p><strong>Pediatric use</strong>: The safety and efficacy of amiodarone in the pediatric population have not been established.<br />
<br />
<strong>Geriatric Use</strong>: Clinical studies of amiodarone did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients. Carefully consider dose selection in an elderly patient. In general, start at the low end of the dosing range in the elderly to reflect the greater frequency of decreased hepatic, renal, or cardiac function, and concomitant disease or other drug therapy.</p>